Corcept Therapeutics | CORT - Operating Expenses

Stock Price
32.15
Daily Change
-0.24 -0.74%
Monthly
-18.87%
Yearly
-42.60%
Q1 Forecast
31.18

Corcept Therapeutics reported $197.64M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 266.6M 23.72M Dec/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
ANI Pharmaceuticals USD 217.93M 287.88M Dec/2025
Ardelyx USD 105.66M 6.4M Sep/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 146.03M 27.79M Sep/2025
BioMarin Pharmaceutical USD 676.18M 131.65M Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Canopy Growth CAD 80.99M 8.64M Sep/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
J&J USD 18.97B 2.38B Dec/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Lexicon Pharmaceuticals USD 57M 10.54M Jun/2024
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Novartis USD 9.77B 401M Sep/2025
Omeros USD 59.16M 20.13M Jun/2024
Pacira USD 193.68M 27.32M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Supernus Pharmaceuticals USD 197.75M 54.54M Dec/2025
TG Therapeutics USD 142.08M 9.74M Dec/2025